High-throughput protein crystallography and drug discovery

Area of Science:

• Structural Biology
• Biochemistry
• Drug Discovery

Background:

• Single crystal X-ray diffraction is crucial for determining protein-small molecule interactions and 3D structures.
• Traditional methods faced limitations due to the need for highly purified proteins and lack of automation.
• Structure-based drug design (SBDD) has become a key discipline in pharmaceutical research, yielding marketed drugs.

Purpose of the Study:

• To review technologies for high-throughput protein crystallography in drug discovery.
• To highlight advancements in automating protein crystallization, data collection, and structural analysis.
• To provide insights for chemists and biologists interested in SBDD.

Main Methods:

• Automation of protein crystallization and data collection.
• Processing of X-ray diffraction data for structural information.
• Application of 3D protein structures for drug discovery and lead optimization.

Main Results:

• Significant increase in the use of crystal structures for drug targets in pharmaceutical research.
• Development of automated techniques to speed up protein crystallography.
• Identification of numerous new potential drug targets from recent genome sequencing.

Conclusions:

• High-throughput protein crystallography is essential for modern drug discovery.
• Automation and advanced techniques are crucial for leveraging genomic data in SBDD.
• This review offers a comprehensive overview of the technologies involved in the protein crystallography pipeline for drug discovery.